{
    "title": "Individual feed for https://seekingalpha.com/feed.xml",
    "link": "https://seekingalpha.com/feed.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-06T02:12:40.670719",
    "items": [
        {
            "title": "Swiss Water: Premium Process, Questionable Moat And A Shaky Coffee Market",
            "link": "https://seekingalpha.com/article/4850885-swiss-water-premium-process-questionable-moat-and-a-shaky-coffee-market?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-06T07:07:52",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Lock 8% By Horizon Technology Finance's Baby Bonds For Your Ladder Portfolio",
            "link": "https://seekingalpha.com/article/4850884-lock-8-percent-by-horizon-technology-finance-baby-bonds-ladder-portfolio?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-06T06:47:28",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "CVS: FY 2026 Margin Recovery, Well Covered Dividends, And Cheap Valuations",
            "link": "https://seekingalpha.com/article/4850883-cvs-fy2026-margin-recovery-well-covered-dividends-and-cheap-valuations?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-06T06:38:16",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Why An Investment Process Matters, Especially In Volatile Markets",
            "link": "https://seekingalpha.com/article/4850886-investment-process-matters-especially-volatile-markets?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-06T06:25:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Top Line Data for Deramiocel in Duchenne Muscular Dystrophy Transcript",
            "link": "https://seekingalpha.com/article/4850828-capricor-therapeutics-inc-capr-discusses-hopeminus-3-phase-iii-top-line-data-for-deramiocel?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-06T06:18:57",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        }
    ]
}